Aurimmed Pharma Inc entered the industry of Commercial Medical Research in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Amir Pesyan by calling (801) 990-4440 during business hours. You can also write to the business’ Single Location at 2150 South 1300 East # 500, Salt Lake City, Utah UT 84106. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Aurimmed Pharma Inc |
| Representative: | Amir Pesyan |
| Place of Business: | 2150 South 1300 East # 500, Salt Lake City, UT 84106 |
| Contact Number: | (801) 990-4440 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2008 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Aurimmed Pharma Inc is a company operating from Salt Lake, Utah providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Aurimmed Pharma Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Amir Pesyan at (801) 990-4440 for related queries, or to locate its Single Location using the coordinates 40.724124,-111.853978.
The Single Location can also be found at the street address 2150 South 1300 East # 500 in Salt Lake City, Utah 84106 and can be engaged online through the company website at , the company Twitter , and Facebook page .